Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(20%)
Results Posted
17%(1 trials)

Phase Distribution

Ph not_applicable
7
70%
Ph phase_1
1
10%
Ph phase_2
2
20%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
2(20.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(6)
Other(1)

Detailed Status

Completed6
Recruiting2
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (10.0%)
Phase 22 (20.0%)
N/A7 (70.0%)

Trials by Status

recruiting220%
unknown110%
not_yet_recruiting110%
completed660%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
10